Epicrispr Reports Early Clinical Activity and Favorable Safety Profile in First-in-Human Epigenetic Editing Study for FSHD ...
Please provide your email address to receive an email when new articles are posted on . A single-dose CRISPR gene-editing infusion lowered blood PCSK9 in three patients with HeFH and advanced CAD. One ...
A condition called CD3 delta SCID is caused by a mutation in the CD3D gene, which prevents the production of the CD3 delta protein that is needed for the normal development of T cells from blood stem ...
Scientists and biotechnologists have heralded the CRISPR-Cas9 gene editing system as revolutionary way to edit DNA, like scissors and a glue stick for the genome. But a new study found some ...
Gene-editing tool CRISPR-Cas9 has garnered significant amounts of positive press in recent months, as the promise of gene editing could help with medicine and alter DNA for the better. But a new study ...
The CRISPR-based genome editing toolbox is packed with powerful refinements. The latest of these, prime editing (PE), was first reported in Nature in 2019 by David Liu’s group. Using a prime editing ...
Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR genome editing—accurately predicting guide RNA (gRNA) activity. Unlike previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results